Ibogaine microdosing in a patient with bipolar depression: case report
Outcomes Case report moderate
AI-extracted · unverified · confirm at source
Microdosing (3mg/72h, 12 weeks) in treatment-resistant bipolar II: 60% HAM-D improvement, no hypomania, stable cardiovascular. Single case, Brazilian regulatory context.
Dosing: 3mg every 72 hours (sub-psychoactive) (oral)
Sample size: 1